We have located links that may give you full text access.
Temperature-controlled Vapor Deposition of Highly Conductive P-type Reduced Molybdenum Oxides by Hydrogen Reduction.
Journal of Physical Chemistry Letters 2018 December 12
Reduced molybdenum oxide, generally MoO3-x, is a family of conductive metal oxides. During the reduction from MoO3 to various MoO3-x phases, the dielectric material becomes increasingly metallic all the way to MoO2. The interesting property through oxygen control has recently intrigued research of the MoO3-x family in multiple research areas including electrical and electrochemical application. One of the research difficulties in reduced molybdenum oxide is the lack of effective tools to control the oxygen level. Herein, we report a facile synthesis method by temperature-controlled synthesis of triangular MoO2 and square Mo4O11. The triangular and square flakes show a metallic behavior in our DC measurement with a conductivity as high as ~940 S/cm and ~28 S/cm respectively. Further Mott-Schottky analysis of samples regrown on carbon fiber paper (CFP) reveals the hole mobility as high as 105 - 108 cm2 V-1 s-1. The decrease in oxygen level from Mo4O11 to MoO2 affects the density of states mapped in Mo 4d orbitals, leading to a higher conductivity for triangular MoO2. The excessive hole carriers and p-type behavior in Mott-Schottky measurement at high frequencies could be attributed to potential oxygen acceptors and molybdenum vacancies resulted from low reduction power of hydrogen.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app